Ozempic is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, administered as a once-weekly subcutaneous injection
Semaglutide, tirzepatide, and retatrutide are among the most effective peptides for weight loss
It holds no marketing authorisation from the MHRA or EMA, meaning no approved reconstitution or stability guidelines exist for use in the UK
Extended use isnt well-studied in humans, so most experts recommend cycling it, typically 48 weeks on, followed by a few weeks off, to support safety and effectiveness.
With same-day prescriptions available, you can begin your journey towards meaningful weight loss without delay, gaining control over your health and well-being